DOI QR코드

DOI QR Code

소아에서 마이코플라스마 폐렴과 바이러스 폐렴의 임상적 특징 비교: 다기관 단면연구

Clinical features of Mycoplasma pneumonia in comparison with viral pneumoina in children: A multicenter, cross-sectional study

  • 안세환 (강동성심병원 소아청소년과) ;
  • 조홍제 (강동성심병원 소아청소년과) ;
  • 백혜성 (강동성심병원 소아청소년과) ;
  • 성명순 (인제대학교 해운대백병원 소아청소년과) ;
  • 윤정원 (서남대학교 명지병원 소아청소년과) ;
  • 최선희 (경희대학교병원 소아청소년과) ;
  • 신윤호 (강남차병원 소아청소년과) ;
  • 한만용 (분당차병원 소아청소년과)
  • An, Se Hwan (Department of Pediatrics, Kangdong Sacred Heart Hospital) ;
  • Cho, Hong Je (Department of Pediatrics, Kangdong Sacred Heart Hospital) ;
  • Baek, Hey-Sung (Department of Pediatrics, Kangdong Sacred Heart Hospital) ;
  • Sung, Myong Soon (Department of Pediatrics, Inje University Haeundae Paik Hospital) ;
  • Yoon, Jung Won (Department of Pediatrics, Myongji Hospital, Seonam University College of Medicine) ;
  • Choi, Sun Hee (Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University School of Medicine) ;
  • Shee, Youn Ho (Department of Pediatrics, CHA Gangnam Medical Center, CHA University School of Medicine) ;
  • Han, Man Yong (Department of Medicine, CHA Bundang Medical Center, CHA University School of Medicine)
  • 투고 : 2017.09.08
  • 심사 : 2017.10.31
  • 발행 : 2018.05.31

초록

Purpose: This study was conducted to compare clinical features between Mycoplasma pneumonia and viral pneumonia. Methods: We retrospectively analyzed the medical records of 428 patients requiring hospitalization among children younger than 18 years of age in 5 hospitals in Seoul and Gyeonggi-do. There were 131 patients with M. pneumonia and virus coinfection, 167 patients with M. pneumonia without virus coinfection, and 130 patients with viral pneumonia. All subjects had radiographic evidence of pneumonia with specimens available for both M. pneumonia and viral testing. Virus was identified using the polymerase chain reaction assay in a nasopharyngeal or oropharyngeal swab. M. pneumoniae pneumonia was diagnosed serologically. Results: Human rhinovirus was detected in 60.3% (79 of 131) of children with M. pneumonia accompanied by virus coinfection. Respiratory syncytial virus (RSV) was detected in 38.2% (50 of 130) of children with viral pneumonia. The mean age was significantly lower in the viral pneumonia group than in the M. pneumonia group with and without virus coinfection. The sex distribution did not differ significantly among the 3 study groups. The procalcitonin level was higher in viral pneumonia and erythrocyte sedimentation rate level was higher in the M. pneumonia group although no significant difference was found in C-reactive protein level between the M. pneumonia and viral pneumonia groups. Conclusion: Clinical features and inflammatory markers between M. pneumonia and viral pneumonia may be useful for the treatment of community-acquired pneumonia.

키워드

참고문헌

  1. Pfuntner A, Wier LM, Stocks C. Most frequent conditions in U.S. Hospitals, 2011: Statistical Brief #162. In: Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD): Agency for Healthcare Research and Quality (US), 2006.
  2. Lee GE, Lorch SA, Sheffler-Collins S, Kronman MP, Shah SS. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics 2010;126:204-13. https://doi.org/10.1542/peds.2009-3109
  3. Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Infect 2008;56:326-31. https://doi.org/10.1016/j.jinf.2008.02.018
  4. Niitu Y, Hasegawa S, Suetake T, Kubota H, Komatsu S, Horikawa M. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. J Pediatr 1970;76:438-43. https://doi.org/10.1016/S0022-3476(70)80485-1
  5. Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 2010;16:613-6. https://doi.org/10.1111/j.1469-0691.2009.02968.x
  6. Peuchant O, Menard A, Renaudin H, Morozumi M, Ubukata K, Bebear CM, et al. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis. J Antimicrob Chemother 2009;64:52-8. https://doi.org/10.1093/jac/dkp160
  7. Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clin Infect Dis 2012;55:1642-9. https://doi.org/10.1093/cid/cis784
  8. Chang MW, Kim KH, Park ID, Song GY, Kim SW, Lee EY, et al. Isolation of Mycoplasma pneumoniae and antimicrobial susceptibilities of the isolates(III). J Life Sci 2005;15:479-85. https://doi.org/10.5352/JLS.2005.15.3.479
  9. Hong KB, Choi EH, Lee HJ, Lee SY, Cho EY, Choi JH, et al. Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011. Emerg Infect Dis 2013;19:1281-4. https://doi.org/10.3201/eid1908.121455
  10. Lee E, Cho HJ, Hong SJ, Lee J, Sung H, Yu J. Prevalence and clinical manifestations of macrolide resistant Mycoplasma pneumoniae pneumonia in Korean children. Korean J Pediatr 2017;60:151-7. https://doi.org/10.3345/kjp.2017.60.5.151
  11. Ahn HS, Shin HY, editors. Hong Chang Eui pediatrics. 11th ed. Seoul: Mirae N, 2016:697.
  12. Sensini A, Zuccherini F, Cerboni1 G, Galullo M, Meli L, Maso GD, et al. Serological diagnosis of Mycoplasma pneumoniae infection: a complicated puzzle. Microbiol Med 2012;27:171-6.
  13. Iwane MK, Prill MM, Lu X, Miller EK, Edwards KM, Hall CB, et al. Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis 2011;204:1702-10. https://doi.org/10.1093/infdis/jir634
  14. Hayden FG. Rhinovirus and the lower respiratory tract. Rev Med Virol 2004;14:17-31. https://doi.org/10.1002/rmv.406
  15. Jartti T, Lee WM, Pappas T, Evans M, Lemanske RF Jr, Gern JE. Serial viral infections in infants with recurrent respiratory illnesses. Eur Respir J 2008;32:314-20. https://doi.org/10.1183/09031936.00161907
  16. Garcia-Garcia ML, Calvo C, Pozo F, Villadangos PA, Perez-Brena P, Casas I. Spectrum of respiratory viruses in children with community-acquired pneumonia. Pediatr Infect Dis J 2012;31:808-13. https://doi.org/10.1097/INF.0b013e3182568c67
  17. Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372:835-45. https://doi.org/10.1056/NEJMoa1405870
  18. Pavia AT. Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis 2011;52 Suppl 4:S284-9. https://doi.org/10.1093/cid/cir043
  19. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011;53:e25-76. https://doi.org/10.1093/cid/cir531
  20. Jacobs JW, Lund PK, Potts JT Jr, Bell NH, Habener JF. Procalcitonin is a glycoprotein. J Biol Chem 1981;256:2803-7.
  21. Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000;26: 1193-200. https://doi.org/10.1007/s001340000624
  22. Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 2004;89:1512-25. https://doi.org/10.1210/jc.2002-021444
  23. Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000;28:977-83. https://doi.org/10.1097/00003246-200004000-00011
  24. Baer G, Baumann P, Buettcher M, Heininger U, Berthet G, Schafer J, et al. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial. PLoS One 2013;8:e68419. https://doi.org/10.1371/journal.pone.0068419
  25. Esposito S, Tagliabue C, Picciolli I, Semino M, Sabatini C, Consolo S, et al. Procalcitonin measurements for guiding antibiotictreatment in pediatric pneumonia. Respir Med 2011;105:1939-45. https://doi.org/10.1016/j.rmed.2011.09.003
  26. Moulin F, Raymond J, Lorrot M, Marc E, Coste J, Iniguez JL, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child 2001;84:332-6. https://doi.org/10.1136/adc.84.4.332
  27. Toikka P, Irjala K, Juven T, Virkki R, Mertsola J, Leinonen M, et al. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J 2000;19: 598-602. https://doi.org/10.1097/00006454-200007000-00003
  28. Stockmann C, Ampofo K, Killpack J, Williams DJ, Edwards KM, Grijalva CG, et al. Procalcitonin accurately identifies hospitalized children with low risk of bacterial community-acquired pneumonia. J Pediatric Infect Dis Soc 2018;7:46-53. https://doi.org/10.1093/jpids/piw091
  29. Menendez R, Sahuquillo-Arce JM, Reyes S, Martinez R, Polverino E, Cilloniz C, et al. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest 2012;141: 1537-45. https://doi.org/10.1378/chest.11-1446
  30. Nascimento-Carvalho CM, Cardoso MR, Barral A, Araujo-Neto CA, Guerin S, Saukkoriipi A, et al. Procalcitonin is useful in identifying bacteraemia among children with pneumonia. Scand J Infect Dis 2010;42: 644-9. https://doi.org/10.3109/00365541003796775

피인용 문헌

  1. Early diagnostic value of the antimycoplasma antibody (IgM) inMycoplasma pneumoniaepneumonia: A single-center study in 2015 vol.7, pp.3, 2019, https://doi.org/10.4168/aard.2019.7.3.129
  2. Clinical efficacy of respiratory virus detection by using the FilmArray method in children admitted with respiratory infection vol.9, pp.1, 2018, https://doi.org/10.4168/aard.2021.9.1.12